Patent · US Active

GPR120 receptor agonists and uses thereof

US8598374B2 · kind B2 · utility

5Cited by

8References

9Claims

0Family size

Assignee

Metabolex, Inc. · US

Inventors

Dong-Fang Shi · Fremont, US
Jiangao Song · Cupertino, US
Christopher J. Rabbat · San Jose, US
Jingyuan Ma · Sunnyvale, US
Aaron Novack · San Jose, US
Imad Nashashibi · San Jose, US
Xin Chen · Lexington, US
Phuongly Pham · Hayward, US

Key dates

Filing date	Oct 5, 2012
Grant date	Dec 3, 2013
Priority date	—
Expiry date	Oct 5, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D407/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.